Intense Treatment Regimen With Intravitreal Aflibercept Injection
Clinical trial NCT03594461 · UNKNOWN
Trial details
- NCT number
- NCT03594461
- Sponsor
- Vitreous -Retina- Macula Consultants of New York
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-11
- Primary completion
- 2020-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.